U.S. Physical Therapy (NYSE:USPH) Given New $98.00 Price Target at Barrington Research

U.S. Physical Therapy (NYSE:USPH) had its price objective decreased by Barrington Research from $108.00 to $98.00 in a research note released on Friday morning,Benzinga reports. Barrington Research currently has an outperform rating on the stock. Barrington Research also issued estimates for U.S. Physical Therapy’s Q3 2025 earnings at $0.67 EPS and Q3 2026 earnings at $0.79 EPS.

USPH has been the subject of several other reports. Citizens Jmp raised U.S. Physical Therapy to a “strong-buy” rating in a report on Monday, December 16th. JMP Securities started coverage on U.S. Physical Therapy in a report on Monday, December 16th. They set an “outperform” rating and a $113.00 price objective for the company. William Blair reaffirmed a “market perform” rating on shares of U.S. Physical Therapy in a report on Thursday. JPMorgan Chase & Co. lifted their price objective on U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a report on Tuesday, December 3rd. Finally, Bank of America raised U.S. Physical Therapy from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $100.00 to $115.00 in a report on Monday, December 16th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $111.50.

U.S. Physical Therapy Stock Down 1.6 %

USPH opened at $81.08 on Friday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. The business has a 50 day simple moving average of $88.20 and a 200-day simple moving average of $87.65. The stock has a market capitalization of $1.22 billion, a P/E ratio of 86.26, a P/E/G ratio of 3.54 and a beta of 1.48. U.S. Physical Therapy has a 12 month low of $76.18 and a 12 month high of $113.63.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing the consensus estimate of $0.69 by ($0.04). The business had revenue of $180.45 million during the quarter, compared to analyst estimates of $173.10 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. On average, equities analysts anticipate that U.S. Physical Therapy will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 14th will be given a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a yield of 2.22%. The ex-dividend date is Friday, March 14th. U.S. Physical Therapy’s payout ratio is 95.65%.

Insiders Place Their Bets

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of the firm’s stock in a transaction on Monday, December 9th. The stock was sold at an average price of $96.25, for a total transaction of $49,665.00. Following the completion of the transaction, the chief financial officer now owns 20,469 shares of the company’s stock, valued at approximately $1,970,141.25. This trade represents a 2.46 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 1.70% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On U.S. Physical Therapy

Hedge funds have recently bought and sold shares of the stock. CBIZ Investment Advisory Services LLC grew its position in shares of U.S. Physical Therapy by 59.8% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company’s stock valued at $29,000 after purchasing an additional 122 shares during the period. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of U.S. Physical Therapy in the fourth quarter valued at $39,000. Venturi Wealth Management LLC grew its position in shares of U.S. Physical Therapy by 3,200.0% in the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company’s stock valued at $64,000 after purchasing an additional 704 shares during the period. KBC Group NV grew its position in shares of U.S. Physical Therapy by 68.6% in the third quarter. KBC Group NV now owns 774 shares of the company’s stock valued at $66,000 after purchasing an additional 315 shares during the period. Finally, Lazard Asset Management LLC purchased a new stake in shares of U.S. Physical Therapy in the fourth quarter valued at $84,000.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.